control group:Follow the guidelines for standard treatment.

2 trials

Sponsors

Union Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology, The Third People's Hospital of Shenzhen

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Early Phase 1

A randomized, parallel controlled open-label trial for the efficacy and safety of Prolongin (Enoxaparin Sodium Injection) in the treatment of adult patients with novel coronavirus pneumonia (COVID-19)

Active, not recruitingChiCTR2000030701

The Third People's Hospital of ShenzhenNovel Coronavirus Pneumonia (COVID-19)

Start: 2020-03-10Updated: 2020-03-16

Study for the efficacy and safety of Prolongin (Enoxaparin Sodium Injection) in treatment of novel coronavirus pneumonia (COVID-19) adult common patients

Active, not recruitingChiCTR2000030700

Union Hospital affiliated to Tongji Medical College of Huazhong University of Science and TechnologyNovel Coronavirus Pneumonia (COVID-19)

Start: 2020-03-09Updated: 2020-03-16